ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MYXR Mycelx Technologies Corporation

50.00
0.00 (0.00%)
04 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mycelx Technologies Corporation LSE:MYXR London Ordinary Share COM SHS USD0.025 (DI) (REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 50.00 40.00 60.00 50.00 50.00 50.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Water Supply 10.91M -3.71M -0.1612 -3.10 11.49M

MyCelx Technologies Corporation Result of AGM

09/07/2024 2:23pm

RNS Regulatory News


RNS Number : 7284V
MyCelx Technologies Corporation
09 July 2024
 

9 July 2024

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Result of Annual Meeting

 

 

The Company is pleased to announce that, at its Annual Meeting held on 9 July 2024 at the offices of Canaccord Genuity, 88 Wood Street, London, EC2V 7QR, the resolutions set out in the Notice of Annual Meeting were duly passed on a Poll.

 

Full details of the resolutions passed are set out in the Notice of Meeting which is available on the Company's website www.mycelx.com.

 

Resolutions

For / Discretion

Against

Total

Vote withheld*

Number

%

Number

%

1A To elect Tom Lamb as a Director

 

11,927,255

 

100.00

 

-

 

-

11,927,255

-

1B To elect Connie Mixon as a Director

11,927,255

 

100.00

 

-

 

 

 

-

11,927,255

 

-

1C To elect Haluk (Hal) Alper as a Director

 

11,927,255

 

100.00

-

-

11,927,255

 

-

1D To elect Andre Schnabl as a Director

 

11,927,255

 

100.00

-

-

11,927,255

 

 

-

 

2. Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm

 

11,927,255

 

100.00

-

-

11,927,255

 

-

 

*'Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Bobbie Hilliam

Ana Ercegovic

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

 

Notes to Editors

Through its revolutionary patented water technology with a mission to reduce the impact of industry on the environment, MYCELX brings its customers material benefits in terms of supporting environmental goals, performance enhancement, cost savings and small footprint. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million as well as removal of other emerging contaminants in water streams. MYCELX supports its international customers across the oil & gas value chain by ensuring clean water discharge or reuse and in groundwater remediation for industrial and military sites. MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

 

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUKUORSRUBRAR

1 Year Mycelx Technologies Chart

1 Year Mycelx Technologies Chart

1 Month Mycelx Technologies Chart

1 Month Mycelx Technologies Chart

Your Recent History